Pre-joined clinical-trials-to-equity bridge: 558,973 trial records

Name: Pre-joined clinical-trials-to-equity bridge: 558,973 trial records (1999–2025) resolved to 48K+ sponsors and 1,515 mapped public tickers, with 168,131 labeled catalyst events carrying 1d/5d/20d forward equity returns and volatility, plus FDA application links, patent cross-references, MeSH/ICD-10 condition mappings and trial-level outcome labels
Creator: Quantlens

QUANTLENSA5 · direct accessManage supplier listing

Pre-joined clinical-trials-to-equity bridge: 558,973 trial records (1999–2025) resolved to 48K+ sponsors and 1,515 mapped public tickers, with 168,131 labeled catalyst events carrying 1d/5d/20d forward equity returns and volatility, plus FDA application links, patent cross-references, MeSH/ICD-10 condition mappings and trial-level outcome labels

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Quantlens and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Financial Exchanges & DataHealth Care Technology
Instruments: equitiesoptions

Dataset card

Type: not stated
Format: Columnar Parquet partitioned by year/event date, DuckDB/Polars ready, delivered by presigned download with SHA-256 verification; Python/R compatible with documented schemas and QA logs
Volume: 558,973 trial records; 48,000+ sponsor entities; 1,515 mapped tickers; 168,131 labeled catalyst events with forward-return columns; plus separate sponsor and catalyst tables — a multi-table Parquet lake partitioned by year/event date
Users: N/A — product is sold as permissive fixed-price dataset licences ($799 Core / $1,999 Pro per licence) with presigned file delivery, so there is no registered-user base; buyer count is undisclosed
History: 26 years
Update frequency: not stated
Growth: Active — dataset refreshed daily with last build 2025-12-06, a versioned v1 release, and a published 'Ultra Pro' roadmap (endpoint/p-value extraction, adverse-event classification, PubMed linkage, PI/KOL investigator network)
Launched: ~2024–2025 — the current release is labelled v1 and the dataset build stamp is 2025-12-06; no dated artifact on the site predates 2025, so commercial availability of this pack is bounded to roughly 2025
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site